Search our suppliers catalog
BioVision
BioVision
News about BioVision
Exploring Targeted Therapeutics Through Biosimilar Monoclonal Antibodies
Biosimilars are highly similar to, but have no clinically meaningful differences when compared with the original biological drug. Biosimilar antibodies are produced by recombinant DNA technology and expressed in CHO cells. These drugs have been broadly employed in the treatment of various cancers and autoimmune diseases, and most recently as therapy against the SARS-CoV-2 coronavirus. Check out BioVision’s selection of biosimilar monoclonal antibodies to study and improve targeted therapy strategies.
Please check the product flyer for more information: Biosimilar Antibodies Flyer
Info BioVision
Products for Life Science research and drug discovery.
BioVision develops and offers a wide variety of products including assay kits, antibodies, recombinant proteins & enzymes, and other innovative research tools for studying Apoptosis, Metabolism, Cell Proliferation, Cellular Stress, Cell Damage and Repair, Diabetes, Obesity and Metabolic Syndrome, Stem Cell Biology, Gene Regulation, Signal Transduction, etc.
For more information:
http://www.biovision.com
BioVision develops and offers a wide variety of products including assay kits, antibodies, recombinant proteins & enzymes, and other innovative research tools for studying Apoptosis, Metabolism, Cell Proliferation, Cellular Stress, Cell Damage and Repair, Diabetes, Obesity and Metabolic Syndrome, Stem Cell Biology, Gene Regulation, Signal Transduction, etc.
For more information:
http://www.biovision.com
Een moment geduld a.u.b. De resultaten worden opgehaald.
-
Productclonecat nrDownload